TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Biotec Betaglucans AS
Closing information (x1000 NOK)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
32,308
|
16,190
|
25,901 |
| Financial expenses |
1,777
|
2,150
|
150 |
| Earnings before taxes |
3,417
|
2,359
|
66,138 |
| Total assets |
33,234
|
22,608
|
26,288 |
| Current assets |
25,263
|
19,643
|
24,116 |
| Current liabilities |
19,248
|
9,039
|
9,078 |
| Equity capital |
13,986
|
13,569
|
17,210 |
| - share capital |
1,000
|
1,000
|
1,000 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
42.1%
|
60.0%
|
65.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.6%
|
14.6%
|
255.3% |
| Return on assets (ROA) |
15.6%
|
19.9%
|
252.2% |
| Current ratio |
131.2%
|
217.3%
|
265.7% |
| Return on equity (ROE) |
24.4%
|
17.4%
|
384.3% |
| Change turnover |
16,118
|
-9,711
|
-23,723 |
| Change turnover % |
100%
|
-37%
|
-48% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.